Table 2.

Patients’ baseline characteristics and stimulation parameters

Cancer patients	N = 48
Age (y)	32.81 ± 4.07
AFC	12.89 ± 5.6
Basal FSH (IU/l)	6.65 ± 2
AMH (ng/ml)	2.16 ± 1.49
Total gonadotropin consumption (IU)	3350 ± 964
Peak serum E2 levels (pg/ml)	1134 ± 756
Duration of stimulation (days)	9.5 ± 2.33
No. of oocytes retrieved	14.04 ± 8.83
No. of MII oocytes	11.38 ± 8.84

Values are expressed as mean ± standard deviation

AFC antral follicle count; E2 estradiol; MII metaphase II